Br J Haematol. 2012 Oct;159(2):252-5.

Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.

Ferreri AJ, Bruno Ventre M, Donadoni G, Cattaneo C, Fumagalli L, Foppoli M, Mappa S, Govi S, Nicola MD, Rossi G, Tirelli U, Caligaris-Cappio F, Spina M, Re A.
SourceDepartment of Onco-Haematology, Unit of Lymphoid Malignancies, Milan, Italy. andres.ferreri@hsr.it.


«  indice delle pubblicazioni più recenti